BISAGNI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 97
EU - Europa 89
AS - Asia 64
AF - Africa 2
Totale 252
Nazione #
US - Stati Uniti d'America 96
CN - Cina 52
SE - Svezia 27
IE - Irlanda 25
FI - Finlandia 16
IT - Italia 11
SG - Singapore 4
TR - Turchia 4
FR - Francia 3
CI - Costa d'Avorio 2
DE - Germania 2
IN - India 2
IR - Iran 2
NL - Olanda 2
CA - Canada 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
UA - Ucraina 1
Totale 252
Città #
Chandler 27
Dublin 25
Dearborn 12
Beijing 9
Shanghai 9
New York 8
Ashburn 7
Nanjing 6
Izmir 4
Jinan 4
Parma 4
Princeton 4
Changsha 3
Hebei 3
Wilmington 3
Abidjan 2
Fremont 2
Hefei 2
Jiaxing 2
Kunming 2
Nanchang 2
Seattle 2
Tianjin 2
Ann Arbor 1
Bremen 1
Changchun 1
Guangzhou 1
Haikou 1
Hangzhou 1
Leawood 1
Norwalk 1
Pune 1
Rio Saliceto 1
Rockville 1
Shenyang 1
Singapore 1
Sorø 1
Taizhou 1
Toronto 1
Verona 1
Totale 161
Nome #
P-027Cancer stem cells marker CD44 and Notch activation predict unfavorable prognosis in metastatic colon cancer patients treated with anti VEGF-therapy 71
Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer 70
Cancer stem cells related marker CD44 and Notch activation in metastatic colon cancer patients 61
Higher expression of MIR-133b is associated with better efficacy of erlotinib as the second or third line in non-small cell lung cancer patients 56
Totale 258
Categoria #
all - tutte 889
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 889


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202048 12 5 0 1 2 11 5 0 2 10 0 0
2020/20219 0 0 0 1 2 0 0 0 3 0 3 0
2021/202221 0 0 0 3 2 0 1 1 1 1 3 9
2022/202385 9 13 5 5 9 8 2 3 29 0 2 0
2023/202439 0 5 0 0 2 16 3 3 2 1 1 6
2024/20252 2 0 0 0 0 0 0 0 0 0 0 0
Totale 258